MENU
+Compare
NHPAP
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$17.73
Change
+$0.18 (+1.03%)

NHPAP stock forecast, quote, news & analysis

National Healthcare Properties Inc is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing operating properties (SHOP) and outpatient medical facilities (OMF), located in the United States... Show more

NHPAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for NHPAP with price predictions
Aug 14, 2025

NHPAP's Stochastic Oscillator sits in overbought zone for 6 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NHPAP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NHPAP broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NHPAP just turned positive on August 06, 2025. Looking at past instances where NHPAP's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NHPAP advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 255 cases where NHPAP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NHPAP's P/B Ratio (0.000) is slightly lower than the industry average of (1.914). NHPAP has a moderately low P/E Ratio (0.000) as compared to the industry average of (42.971). NHPAP's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.189). NHPAP has a moderately high Dividend Yield (0.104) as compared to the industry average of (0.065). NHPAP's P/S Ratio (0.000) is slightly lower than the industry average of (6.624).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NHPAP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

NHPAP paid dividends on July 15, 2025

National Healthcare Properties Inc NHPAP Stock Dividends
А dividend of $0.46 per share was paid with a record date of July 15, 2025, and an ex-dividend date of July 03, 2025. Read more...
A.I.Advisor
published Highlights

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 8.33B. The market cap for tickers in the group ranges from 3.42M to 116.34B. ANTM holds the highest valuation in this group at 116.34B. The lowest valued company is HRAA at 3.42M.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 12%. STRW experienced the highest price growth at 6%, while WELL experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was 35%. For the same stocks of the Industry, the average monthly volume growth was 35% and the average quarterly volume growth was 53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 14
P/E Growth Rating: 71
Price Growth Rating: 51
SMR Rating: 84
Profit Risk Rating: 75
Seasonality Score: -33 (-100 ... +100)
View a ticker or compare two or three
NHPAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ManagedHealthCare

Profile
Fundamentals
Details